- ResMed is now poised to provide a broader suite of solutions for COPD treatment
- Propeller Health will operate as a standalone business, maintaining its COPD and asthma product solutions, as well as its partnerships with pharmaceutical and healthcare organizations
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190107005976/en/